TickerFactsScreenerDevelopers

Alaunos Therapeutics, Inc. (TCRT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $11.0K2010: $186.0K2011: $1.16M2012: $1.56M2013: $132.0K2014: $193.0K2015: $412.0K2016: $551.0K2017: $737.0K2018: $459.0K2019: $284.0K2020: $9.78M2021: $3.32M2022: $216.0K2023: $197.0K2024: $02025: $98.0K$98.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$98.0K—
2024$0-100.0%
2023$197.0K-8.8%
2022$216.0K-93.5%
2021$3.32M-66.0%
2020$9.78M+3343.0%
2019$284.0K-38.1%
2018$459.0K-37.7%
2017$737.0K+33.8%
2016$551.0K+33.7%
2015$412.0K+113.5%
2014$193.0K+46.2%
2013$132.0K-91.5%
2012$1.56M+34.9%
2011$1.16M+521.5%
2010$186.0K+1590.9%
2009$11.0K—